Your browser doesn't support javascript.
loading
Expression Levels of JARID1B, Hes1 and MMP-9 Genes in CML Patients Treated with Imatinib Mesylate / 中国实验血液学杂志
Journal of Experimental Hematology ; (6): 1071-1076, 2019.
Article in Chinese | WPRIM | ID: wpr-771837
ABSTRACT
OBJECTIVE@#To explore the relationship between the expression levels of JARID1B,Hes1 and MMP-9 genes and the stages of chronic myelogenous leukemia(CML) and the curative effect of imatinib mesylate (IM).@*METHODS@#Peripheral blood samples of 15 cases of CML in chronic phase and 10 cases of CML in progressive phase were collected from the Hematology Department of Taihe Hospital affiliated to Hubei University of Medicine and 15 cases of healthy people in the Physical Examination Center. CML patients were divided into effective group and ineffective group based on the efficacy after treatment with IM, then real-time PCR was used to detect the expression levels of JARID1B, Hes1 and MMP-9 mRNA, finally, the differences in the level of gene expression and their correlations with CML stages and IM curative efficacy were analysed.@*RESULTS@#The expression levels of Hes1 and MMP-9 in initially diagnosed patients in chronic and progressive phase without IM treatment were significantly higher than those of health people(P<0.05). There was no significant difference in the expression level of JARID1B between chronic phase patients and health people(P>0.05), but the expression level of JARID1B in the progressive phase patients was higher than that of health people (P<0.05). The expression levels of JARID1B and Hes1 in the IM-effective group were not significantly different from those in the IM-ineffective group (P=0.85,P=0.82), while the expression level of MMP-9 in the IM-effective group [JP2]was significantly lower than that in the IM-ineffective group(P<0.05).@*CONCLUSION@#The expression levels of JARID1B Hes1 and MMP-9 relate with the different phase of CML; The expression levels of JARID1B and Hes1 have not significant relationship with IM curative efficacy, the MMP-9 gene expression level relates with IM curative efficacy.
Subject(s)
Full text: Available Index: WPRIM (Western Pacific) Main subject: Repressor Proteins / Nuclear Proteins / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Matrix Metalloproteinase 9 / Therapeutic Uses / Drug Therapy / Jumonji Domain-Containing Histone Demethylases / Imatinib Mesylate / Transcription Factor HES-1 / Antineoplastic Agents Limits: Humans Language: Chinese Journal: Journal of Experimental Hematology Year: 2019 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Repressor Proteins / Nuclear Proteins / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Matrix Metalloproteinase 9 / Therapeutic Uses / Drug Therapy / Jumonji Domain-Containing Histone Demethylases / Imatinib Mesylate / Transcription Factor HES-1 / Antineoplastic Agents Limits: Humans Language: Chinese Journal: Journal of Experimental Hematology Year: 2019 Type: Article